Inhibition of the Topoisomerase II-DNA Cleavable Complex by theortho-Quinone Derivative of the Antitumor Drug Etoposide (VP-16)

This publication has 10 references indexed in Scilit:

• Enhancement of etoposide (VP-16) cytotoxicity by enzymatic and photodynamically induced oxidative stress
  Anti-Cancer Drugs, 1997
• Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells
  British Journal of Cancer, 1996
• DNA TOPOISOMERASES
  Annual Review of Biochemistry, 1996
• [63] Interactions of phenoxyl radical of antitumor drug, etoposide, with reductants in solution and in cell and nuclear homogenates: Electron spin resonance and high-performance liquid chromatography
  Published by Elsevier ,1994
• Reactions of glutathione with the catechol, the ortho-quinone and the semi-quinone free radical of etoposide Consequences for DNA inactivation
  Biochemical Pharmacology, 1992
• Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II
  Biochemistry, 1991
• Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded ΦX174 DNA
  British Journal of Cancer, 1990
• Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide
  Biochemistry, 1989
• Effects of the ortho-quinone and catechol of the antitumor drug VP-16-213 on the biological activity of single-stranded and double-stranded ΦX174 DNA
  Biochemical Pharmacology, 1988
• Electrochemistry of podophyllotoxin derivatives
  Journal of Electroanalytical Chemistry and Interfacial Electrochemistry, 1985